Stock · ELV · Healthcare
United States · Large Cap · listed since 2001 · Revenue 12 mo. $201.8B
Price as of 11/06/2026
Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States.
Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to individual, employer group risk-based and fee-based, BlueCard, Medicare, Medicaid, and FEP members; health products; a broad array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, and supplemental health insurance benefits. The company also operates in the pharmacy services business; and markets and offers pharmacy services, including home delivery and specialty pharmacies, claims adjudication, formulary management, pharmacy networks, rebate administration, a prescription drug database, and member services, as well as infusion services and injectable therapies through ambulatory infusion centers. In addition, it provides healthcare related services and capabilities, including specialty care enablement and utilization management support for specialized clinical domains; behavioral health and comprehensive care management services; palliative care services and management; virtual care; and payment integrity, subrogation, clinical data exchange through its HealthOS platform, research and data, reporting and clinical analytics, information technology, and business process support services, as well as manages home health, post-acute institutional management, and durable medical equipment costs; and supports plans in managing home and community-based services. The company provides its services under the Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brands. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was incorporated in 2001 and is based in Indianapolis, Indiana.
Original text from the data provider
Summary
49.3 of 100
Mean of the six area values. Each area value is the mean of the stock's ranks among the companies in its sector. 50 is the middle of the sector, not a share of companies beaten.
Analysis
What the price requires
If free cash flow stays at €2.8B (2025), it supports €31.6B. The remaining €52.5B of the market value assume it grows 13.6% a year for 10 years and not at all afterwards.
Required FCF growth per year
13.6%
no growth afterwards
Price to operating cash flow 12.2×, within its usual range.
Middle half of 20 quarters: 11.1× to 15.7×, median 13.7×.
Measures only against its own past, not against what the company is worth. Price as of 11/06/2026.
with respect to the priced-in expectation
with respect to the priced-in expectation
Since the last quarter
Q2 → Q3 2026
7 more unchanged: Revenue, 12 mo., FCF, 12 mo., EBIT margin, FCF margin, Net debt, Shares outstanding, Return on equity
Derivation
Each area value is the average of its metrics' ranks within the sector (0 to 100, 50 is the middle). For metrics where lower is better, the rank is mirrored. The overall value is the average of the area values.
Price as of 11/06/2026.
| Metric | Stock | Sector median | Position in sector |
|---|---|---|---|
| Return on equity | 12.90% | 11.52% | Rank 60 |
| Return on capital (Greenblatt) | 81.94% | 32.55% | Rank 85 |
| EBIT margin | 4.07% | 18.31% | Rank 12 |
| FCF margin | 1.59% | 14.12% | Rank 10 |
| Gross margin | 25.56% | 60.99% | Rank 14 |
| Metric | Stock | Sector median | Position in sector |
|---|---|---|---|
| Revenue growth, 1 year | 12.62% | 8.04% | Rank 76 |
| Earnings growth, 3 years per year | 1.69% | 5.44% | Rank 39 |
| Earnings growth, 5 years per year | 7.26% | 7.00% | Rank 51 |
| Sustainable growth (ROE × retained earnings) | 0.56% | 3.66% | Rank 11 |
| Metric | Stock | Sector median | Position in sector |
|---|---|---|---|
| Earnings yield | 6.00% | 2.90% | Rank 87 |
| FCF yield | 3.39% | 3.63% | Rank 44 |
| EV/saleslower is better | 0.59 | 4.03 | Rank 90 |
| EV/EBITlower is better | 14.48 | 21.73 | Rank 80 |
| Metric | Stock | Sector median | Position in sector |
|---|---|---|---|
| Share price, 1 year | 25.75% | 8.66% | Rank 75 |
| Share price, 6 months | 13.06% | 24.27% | Rank 31 |
| Share price, 3 months | 13.10% | 15.42% | Rank 46 |
| Distance from 52-week high | −4.42% | −7.35% | Rank 63 |
| Metric | Stock | Sector median | Position in sector |
|---|---|---|---|
| Accruals (Sloan)lower is better | 2.28% | 0.30% | Rank 34 |
| Change in share countlower is better | −4.77% | 0.00% | Rank 94 |
| Dividend streak in years | 14 | 10 | Rank 72 |
| Price reaction to results, market-adjusted | −1.90% | 0.05% | Rank 27 |
| Metric | Stock | Sector median | Position in sector |
|---|---|---|---|
| Equity ratio | 36.12% | 48.40% | Rank 26 |
| Net debt/EBITDAlower is better | 2.46 | 1.11 | Rank 24 |
| Debt to equitylower is better | 0.76 | 0.48 | Rank 31 |
| Volatility, 1 yearlower is better | 34.91% | 31.42% | Rank 39 |
Ten years in figures
| Year | Revenue, $B | EBIT margin | FCF, $B | Shares | Net debt, $B |
|---|---|---|---|---|---|
| 2016 | 85.0 | 6.4% | 2.6 | 268M | 11.7 |
| 2017 | 90.0 | 5.5% | 3.4 | 268M | 16.3 |
| 2018 | 92.1 | 6.3% | 2.6 | 254M | 15.3 |
| 2019 | 104.2 | 6.5% | 5.0 | 260M | 16.3 |
| 2020 | 121.9 | 6.3% | 9.7 | 254M | 16.1 |
| 2021 | 138.6 | 6.5% | 7.3 | 247M | 20.0 |
| 2022 | 156.6 | 5.4% | 7.2 | 243M | 18.4 |
| 2023 | 171.3 | 5.1% | 6.8 | 237M | 20.1 |
| 2024 | 176.8 | 5.0% | 4.6 | 233M | 24.4 |
| 2025 | 199.1 | 4.1% | 3.2 | 222M | 23.7 |
3 of 7 StockScorer Score rules met · How the score is built
Elevance Health Inc mainly meets criteria in the Momentum category. Result from 18 strategies checked.
Elevance Health Inc is rated here with the StockScorer Score strategy, the flagship rule set. It compares return and cash-flow metrics with the median of the company's own sector and checks growth and price trend.
3 of 7 rules met
4 of 11 points
Detail data
Excerpt from 18 strategies checked. The full evaluation is visible after a free sign-up.
With a free account, you can see the match across all strategies checked in one complete overview.
Selected fundamental metrics for Elevance Health Inc.
| Metric | Stock | Sector |
|---|---|---|
| P/E ratio | 16.7 | 30.0 |
| P/B ratio | 2.2 | 4.8 |
| Return on equity (ROE) | 12.9% | 11.5% |
| Equity ratio | 36.1% | 48.4% |
| Debt-to-equity (D/E) | 0.76 | 0.48 |
| Dividend yield | 1.6% | 1.3% |
How comparable stocks in the same sector score in the StockScorer model.
| Symbol | Company | Rating |
|---|---|---|
| ELV | Elevance Health Incthis page | |
| CVS | CVS Health Corp | Low3.6 |
| CI | The Cigna Group | Low4.5 |
| HUM | Humana Inc | Low2.7 |
| CNC | Centene Corp | locked |
| UNH | UnitedHealth Group Incorporated | locked |
Signed up in 30 seconds, free.
Learn more about the metrics in the metrics glossary or all rated stocks in the stock overview.
How StockScorer rates every stock is explained on the methodology page.